BR112017014750A2 - métodos para tratamento de diarreia em animais de estimação - Google Patents

métodos para tratamento de diarreia em animais de estimação

Info

Publication number
BR112017014750A2
BR112017014750A2 BR112017014750A BR112017014750A BR112017014750A2 BR 112017014750 A2 BR112017014750 A2 BR 112017014750A2 BR 112017014750 A BR112017014750 A BR 112017014750A BR 112017014750 A BR112017014750 A BR 112017014750A BR 112017014750 A2 BR112017014750 A2 BR 112017014750A2
Authority
BR
Brazil
Prior art keywords
pets
methods
treating diarrhea
diarrhea
treating
Prior art date
Application number
BR112017014750A
Other languages
English (en)
Inventor
Martinod Serge
Original Assignee
Jaguar Animal Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jaguar Animal Health filed Critical Jaguar Animal Health
Publication of BR112017014750A2 publication Critical patent/BR112017014750A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112017014750A 2015-01-09 2016-01-08 métodos para tratamento de diarreia em animais de estimação BR112017014750A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562101663P 2015-01-09 2015-01-09
US201562117927P 2015-02-18 2015-02-18
PCT/US2016/012681 WO2016112312A1 (en) 2015-01-09 2016-01-08 Methods of treating diarrhea in companion animals

Publications (1)

Publication Number Publication Date
BR112017014750A2 true BR112017014750A2 (pt) 2018-06-19

Family

ID=56356484

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017014750A BR112017014750A2 (pt) 2015-01-09 2016-01-08 métodos para tratamento de diarreia em animais de estimação

Country Status (13)

Country Link
US (1) US20180264061A1 (pt)
EP (1) EP3242557A4 (pt)
JP (1) JP2018509382A (pt)
KR (1) KR20170103834A (pt)
CN (1) CN107106536A (pt)
AU (1) AU2016205145A1 (pt)
BR (1) BR112017014750A2 (pt)
CA (1) CA2972996A1 (pt)
CL (1) CL2017001790A1 (pt)
CO (1) CO2017007823A2 (pt)
MX (1) MX2017009011A (pt)
RU (1) RU2017127686A (pt)
WO (1) WO2016112312A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
CA3086826A1 (en) * 2017-12-27 2019-07-04 Suntory Holdings Limited Composition for improving intestinal barrier function
BR112022025741A2 (pt) * 2020-06-19 2023-01-03 Napo Pharmaceuticals Inc Usos de composições compreendendo crofelemer para tratamento de diarreia induzida por quimioterapia (cid)
KR102618266B1 (ko) 2023-09-08 2023-12-27 주식회사 모이스텐 반려동물 복용 편의를 고려한 생분해성 필름 및 이의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0935417B1 (en) * 1996-10-16 2009-05-06 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
DZ2479A1 (fr) * 1997-05-05 2003-02-01 Pfizer Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
EP1921076A1 (en) * 2002-10-11 2008-05-14 Proteotech Inc. systhesis of procyanidin B2
WO2007130893A2 (en) * 2006-05-01 2007-11-15 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
CA2662897C (en) * 2006-09-11 2017-11-07 Tranzyme Pharma, Inc. Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
US8709515B1 (en) * 2009-02-19 2014-04-29 Carmen C. H. Colitz Nutritional supplement method
WO2011044167A1 (en) * 2009-10-06 2011-04-14 University Of California, San Francisco Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
CN102138930A (zh) * 2011-01-04 2011-08-03 海南美兰史克制药有限公司 复方雷贝拉唑钠药物组合物固体制剂
WO2013093655A1 (en) * 2011-12-22 2013-06-27 Glenmark Pharmaceuticals Limited Non-enteric pharmaceutical composition comprising crofelemer
WO2015184101A1 (en) * 2014-05-29 2015-12-03 Jaguar Animal Health, Inc. Methods of treating diarrhea in neonatal and young non-human animals
US20170119834A1 (en) * 2014-05-29 2017-05-04 Jaguar Animal Health, Inc. Methods of Treating Diarrhea in Adult Non-Human Animals
US20170095442A1 (en) * 2014-05-29 2017-04-06 Jaguar Animal Health, Inc. Methods of Treating Salmonella-Induced Diarrhea in Non-Human Animals

Also Published As

Publication number Publication date
CN107106536A (zh) 2017-08-29
CL2017001790A1 (es) 2018-04-06
US20180264061A1 (en) 2018-09-20
CA2972996A1 (en) 2016-07-14
JP2018509382A (ja) 2018-04-05
KR20170103834A (ko) 2017-09-13
CO2017007823A2 (es) 2018-01-05
EP3242557A1 (en) 2017-11-15
RU2017127686A (ru) 2019-02-11
EP3242557A4 (en) 2018-09-05
AU2016205145A1 (en) 2017-07-13
MX2017009011A (es) 2017-10-02
WO2016112312A1 (en) 2016-07-14

Similar Documents

Publication Publication Date Title
AU362358S (en) Pet treat
EP3119188C0 (en) SYSTEM AND METHOD FOR TREATING FARM ANIMALS
HK1244217A1 (zh) 用於治療蛋白質病的方法
BR112016029236A2 (pt) métodos para tratar prurido.
IL249936A0 (en) Methods for treating hypotension
BR112017004533A2 (pt) método para tratamento de sarcoidose pulmonar
HK1257024A1 (zh) 用於治療伴侣動物的aav-epo
BR112015002715A2 (pt) método e aparelho para compartilhar recursos
BR112017027497A2 (pt) Abastecimento de água para um animal
BR112017014750A2 (pt) métodos para tratamento de diarreia em animais de estimação
IL252904A0 (en) Methods and factors for treating diseases
ZA201903448B (en) Device for treating water
GB201414192D0 (en) Apparatus for treating animals
FI20155671A (fi) Menetelmä veden käsittelemiseksi
GB2544893B (en) Grooming apparatus
PL3093190T3 (pl) Przyczepa do leczenia czworonożnych zwierząt
ES1123955Y (es) Noría de ejercicio para mascotas
ES1137255Y (es) Rejilla para desagüe
ES1135628Y (es) Monoboya para vertido controlado
ES1100681Y (es) Comedero para ganado
ES1174283Y (es) Dispositivo de sujecion para mascotas
ES1142112Y (es) Disposición de cepillado para animales
FI20150082A (fi) Hoitoväline
FI20155772A (fi) Menetelmä biolietteen käsittelemiseksi
GB201521953D0 (en) Dogs/cats etc

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: JAGUAR HEALTH, INC. (US)

B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]